| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8acc2ee23441453ac1962d026035770 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate |
2019-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a1d697a1cd132beefac911709835cc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d34a1e7743b00923d092371a9b53f26c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1fad5ab0d1856d95e2e431871e1c6fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_474ba706e3b7ceac6aff40292ae6549b |
| publicationDate |
2019-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CL-2019001366-A1 |
| titleOfInvention |
Buffered formulations exendin (9-39). |
| abstract |
IN THIS MEMORY PHARMACEUTICAL LIQUID FORMULATIONS ARE PROVIDED THAT INCLUDE EXENDIN (9-39) OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME AND A TONICITY MODIFIER IN A FISIOLOGICALLY BUFFER APPROXIMATELY APPROXIMATELY ABOUT 6 WITH A PHADITION OF APPROXIMATELY 6. EMBODIMENTS, THE BUFFERED LIQUID FORMULATION INCLUDES EXENDIN (9-39) OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME IN AN ACETATE BUFFER OR CITRATE BUFFER. METHODS TO TREAT OR PREVENT HYPOGLYCAEMIA IN A SUBJECT WHICH INCLUDES ADMINISTERING THE SUBJECT THE LIQUID BUFFERED FORMULATION ARE ALSO PROVIDED. |
| priorityDate |
2016-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |